Business Context and Reporting Period
This Form 8-K was filed by Legato Merger Corp. II on February 13, 2023, reporting an event dated February 8, 2023. The filing concerns the proposed business combination between Legato and Southland Holdings LLC; it is not an operating or periodic financial report of Southland Holdings, Inc.
- Under the May 25, 2022 merger agreement, a Legato subsidiary is expected to merge with Southland, with Southland surviving as a wholly owned subsidiary of Legato.
- Legato’s Form S-4 registration statement and related proxy statement/prospectus were declared effective on February 1, 2023.
Key Financial and Capital Markets Metrics
- Brian Pratt, Legato’s chairman, purchased 150,000 Legato common shares in the open market on February 8, 2023, at $10.2967 per share.
- Approximately 2.7 million Legato public shares had been submitted for redemption as of the close of business on the purchase date.
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics for Southland or Legato.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial statements or period-over-period operating results. The material update is the insider share purchase and the disclosure of approximately 2.7 million shares submitted for redemption in connection with the proposed transaction.
- The purchased shares will not be voted at the Legato annual meeting.
- Mr. Pratt waived redemption rights for the purchased shares.
- The filing states that the purchases are not expected to affect approval of the transaction because the shares will not be voted.
Guidance, Outlook, Risks, and Unusual Items
- Management commentary indicates that the purchases were intended to reduce the number of shares potentially redeemed for cash and help preserve funds in Legato’s trust account for the combined company.
- Mr. Pratt stated that he purchased the shares based on his confidence in Southland’s business.
- Completion of the transaction remains subject to stockholder approval and other closing conditions, including applicable regulatory and listing requirements.
- Identified risks include failure to complete the transaction, redemption assumptions, transaction costs, competition, economic and regulatory changes, litigation, integration and growth execution, retention of key personnel, and the ability to realize anticipated benefits.
- The filing contains forward-looking statements and cautions that actual results may differ materially. It also states that the Item 7.01 information is furnished and is not deemed filed for Section 18 liability purposes.
Important Facts for Investors to Verify
- Review the definitive proxy statement/prospectus and the Form S-4 for transaction terms, valuation, dilution, redemption mechanics, and closing conditions.
- Verify the final number of redeemed shares and the amount remaining in Legato’s trust account.
- Confirm whether Legato stockholder approval and all other conditions to closing were obtained.
- Review Southland’s financial statements and disclosures separately, as this filing provides no operating or financial performance data.
- Assess the impact of the insider purchase, including the waived redemption rights and the shares’ exclusion from voting.